Evaluation of the hypothalamic–pituitary–adrenal axis in untreated patients with polymyalgia rheumatica and healthy controls

References

• Crofford L. J. The hypothalamic–pituitary–adrenal axis in the pathogenesis of rheumatic diseases. Endocrinol Metab Clin North Am 2002; 31: 1–13
   PubMed Web of Science ®Google Scholar
• Cutolo M., Foppiani L., Minuto F. Hypothalamic–pituitary–adrenal axis impairment in the pathogenesis of rheumatoid arthritis and polymyalgia rheumatica. J Endocrinol Invest 2002; 25: 19–23
   PubMedGoogle Scholar
• Masi A. T., Bijlsma J. W. J., Chikanza I. C., Pitzalis C., Cutolo M. Neuroendocrine, immunologic, and microvascular systems interactions in rheumatoid arthritis: physiopathogenetic and therapeuticperspectives. Semin Arthritis Rheum 1999; 29: 65–81
   PubMed Web of Science ®Google Scholar
• Demir H., Kelestimur F., Tunc M., Kirnap M., Ozugul Y. Hypothalamo–pituitary–adrenal axis and growth hormone axis in patients with rheumatoid arthritis. Scand J Rheumatol 1999; 28: 41–6
   PubMed Web of Science ®Google Scholar
• Gutierrez M. A., Garcia M. E., Rodriguez J. A., Mardonez G., Jacobelli S., Rivero S. Hypothalamic–pituitary–adrenal axis function in patients with active rheumatoid arthritis: a controlled study using insulin hypoglycemia stress test and prolactin stimulation. J Rheumatol 1999; 26: 277–81
   PubMed Web of Science ®Google Scholar
• Cutolo M. The role of the hypothalamus–pituitary–adrenocortical and –gonadal axis in rheumatoid arthritis. Clin Exp Rheumatol 1998; 16: 3–6
   PubMed Web of Science ®Google Scholar
• Wilder R. L. Adrenal and gonadal steroid hormone deficiency in the pathogenesis of rheumatoid arthritis. J Rheumatol Suppl 1996; 44: 10–12
   PubMedGoogle Scholar
• Zietz B., Reber T., Oertel M., Gluck T., Scholmerich J., Straub R. H. Altered function of the hypothalamic stress axes in patients with moderately active systemic lupus erythematosus. II. Dissociation between androstenedione, cortisol, or dehydroepiandrosterone and interleukin 6 or tumor necrosis factor. J Rheumatol 2000; 27: 911–18
   PubMed Web of Science ®Google Scholar
• Johnson E. O., Vlachoyiannopoulos P. G., Skopouli F. N., Tzioufas A. G., Moutsopoulos H. M. Hypofunction of the stress axis in Sjogren's syndrome. J Rheumatol 1998; 25: 1508–14
   PubMed Web of Science ®Google Scholar
• Crofford L. J., Pillemer S. R., Kalogeras K. T., Cash J. M., Michelson D., Kling M. A., et al. Hypothalamic–pituitary–adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum 1994; 37: 1583–92
   PubMed Web of Science ®Google Scholar
• Calis M., Gokce C., Ates F., Ulker S., Izgi H. B., Demir H., et al. Investigation of the hypothalamo–pituitary–adrenal axis (HPA) by 1 microg ACTH test and metyrapone test in patients with primary fibromyalgia syndrome. J Endocrinol Invest 2004; 27: 42–6
   PubMed Web of Science ®Google Scholar
• Evans J. M., Hunder G. G. Polymyalgia rheumatica and giant cell arteritis. Rheum Dis Clin North Am 2000; 26: 493–515
   PubMed Web of Science ®Google Scholar
• Chuang T. Y., Hunder G. G., Ilstrup D. M., Kurland L. T. Polymyalgia rheumatica: a 10‐year epidemiologic and clinical study. Ann Intern Med 1982; 97: 672–80
   PubMed Web of Science ®Google Scholar
• Huebener K. H., Treugut H. Adrenal cortex dysfunction, CT findings. Radiology 1984; 150: 195–9
   PubMed Web of Science ®Google Scholar
• Karstaedt N., Sagel S. S., Stanley R. J., Nelon G. L., Levitt R. C. Computed tomography of the adrenal gland. Radiology 1978; 129: 723–30
   PubMed Web of Science ®Google Scholar
• Vincent J. M., Morrison I. D., Armstrong P., Reznek R. H. The size of normal adrenal glands on computed tomography. Clin Radiol 1994; 49: 453–5
   PubMed Web of Science ®Google Scholar
• Martinez‐Taboada V., Bartolome M. J., Amado J. A., Blanco R., Garcia‐Unzueta M. T., Rodriguez‐Valverde V., et al. Changes in peripheral blood lymphocyte subsets in elderly subjects are associated with an impaired function of the hypothalamic–pituitary–adrenal axis. Mech Ageing Dev 2002; 123: 1477–86
   PubMed Web of Science ®Google Scholar
• Castle S. C. Clinical relevance of age‐related immune dysfunction. Clin Infect Dis 2000; 31: 578–85
   PubMed Web of Science ®Google Scholar
• Cutolo M., Straub R. H. Polymyalgia rheumatica: evidence for a hypothalamic–pituitary–adrenal axis driven disease. Clin Exp Rheumatol 2000; 18: 655–8
   PubMed Web of Science ®Google Scholar
• Pacheco M. J., Amado J. A., Lopez‐Hoyos M., Blanco R., Garcia‐Unzueta M. T., Rodriguez‐Valverde V., et al. Hypothalamic–pituitary–adrenocortical axis function in patients with polymyalgia rheumatica and giant cell arteritis. Semin Arthritis Rheum 2003; 32: 266–72
   PubMed Web of Science ®Google Scholar
• Tsigos C., Papanicolaou D. A., Defensor R., Mitsiadis C. S., Kyrou I., Chrousos G. P. Dose effects of recombinant human interleukin‐6 on pituitary hormone secretion and energy expenditure. Neuroendocrinology 1997; 66: 54–62
   PubMed Web of Science ®Google Scholar
• Straub R. H., Paimela L., Peltomaa R., Scholmerich J., Leirisalo‐Repo M. Inadequately low serum levels of steroid hormones in relation to interleukin‐6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis. Arthritis Rheum 2002; 46: 654–62
   PubMed Web of Science ®Google Scholar
• Cutolo M., Straub R. H., Foppiani L., Prete C., Pulsatelli L., Sulli A., et al. Adrenal gland hypofunction in active polymyalgia rheumatica. Effect of glucocorticoid treatment on adrenal hormones and interleukin 6. J Rheumatol 2002; 29: 748–56
   PubMed Web of Science ®Google Scholar
• Straub R. H., Gluck T., Cutolo M., Georgi J., Helmke K., Scholmerich J., et al. The adrenal steroid status in relation to inflammatory cytokines (interleukin‐6 and tumour necrosis factor) in polymyalgia rheumatica. Rheumatology (Oxford) 2000; 39: 624–31
   PubMed Web of Science ®Google Scholar